Determinants of plasma concentrations of perfluoroalkyl substances in pregnant Norwegian women.
about
Reliability of perfluoroalkyl substances in plasma of 100 women in two consecutive pregnanciesFactors Associated with Maternal Serum Levels of Perfluoroalkyl Substances and Organochlorines: A Descriptive Study of Parous Women in Norway and SwedenMaternal Concentrations of Perfluoroalkyl Substances and Fetal Markers of Metabolic Function and Birth Weight.Changes in serum concentrations of maternal poly- and perfluoroalkyl substances over the course of pregnancy and predictors of exposure in a multiethnic cohort of Cincinnati, Ohio pregnant women during 2003-2006.Perfluoroalkyl substances and time to pregnancy in couples from Greenland, Poland and Ukraine.Perfluoroalkyl substances and ovarian hormone concentrations in naturally cycling womenSerum Biomarkers of Exposure to Perfluoroalkyl Substances in Relation to Serum Testosterone and Measures of Thyroid Function among Adults and Adolescents from NHANES 2011-2012.Perfluoroalkyl acids and time to pregnancy revisited: An update from the Danish National Birth Cohort.Sociodemographic and Perinatal Predictors of Early Pregnancy Per- and Polyfluoroalkyl Substance (PFAS) Concentrations.Exposure to PFOA and PFOS and fetal growth: a critical merging of toxicological and epidemiological data.Serum concentrations of perfluorinated compounds (PFC) among selected populations of children and adults in California.Maternal and Neonatal Levels of Perfluoroalkyl Substances in Relation to Gestational Weight GainPerfluoroalkyl substances and lipid concentrations in plasma during pregnancy among women in the Norwegian Mother and Child Cohort Study.Breastfeeding: a potential excretion route for mothers and implications for infant exposure to perfluoroalkyl acidsDemographic, Reproductive, and Dietary Determinants of Perfluorooctane Sulfonic (PFOS) and Perfluorooctanoic Acid (PFOA) Concentrations in Human ColostrumPerfluoroalkyl substances during pregnancy and validated preeclampsia among nulliparous women in the Norwegian Mother and Child Cohort Study.Perfluoroalkyl and polyfluoroalkyl substances and human fetal growth: a systematic review.Perfluoroalkyl and polyfluoroalkyl substances and measures of human fertility: a systematic review.Brief Report: Plasma Concentrations of Perfluorooctane Sulfonamide and Time-to-pregnancy Among Primiparous Women.Factors affecting the accumulation of perfluoroalkyl substances in human blood.Shorter duration of breastfeeding at elevated exposures to perfluoroalkyl substances.Can profiles of poly- and Perfluoroalkyl substances (PFASs) in human serum provide information on major exposure sources?Oral contraceptive use as a determinant of plasma concentrations of perfluoroalkyl substances among women in the Norwegian Mother and Child Cohort (MoBa) study.An automated high-throughput SPE micro-elution method for perfluoroalkyl substances in human serum.Determinants and Temporal Trends of Perfluoroalkyl Substances in Pregnant Women: The Hokkaido Study on Environment and Children's Health.Maternal Plasma Concentrations of Per- and polyfluoroalkyl Substances and Breastfeeding Duration in the Norwegian Mother and Child CohortMenstrual cycle characteristics as determinants of plasma concentrations of perfluoroalkyl substances (PFASs) in the Norwegian Mother and Child Cohort (MoBa study)
P2860
Q28397823-9C894624-AE63-4919-B152-9CD6864BBC0FQ28553267-2415F7BD-30A8-45F0-8DBD-56725A4D6A97Q33564787-4229262B-CC33-45F6-8B0F-30E9F7DBCB16Q34074733-B4587989-1294-4D21-979E-CC26AF534B72Q35339240-896C48F1-BA18-4421-AEB0-A8A544639357Q35562877-D0978A55-D01C-4FE3-8C5C-9CCDE4CA8488Q35790907-B1DB5B83-FB72-403C-82C3-0658CB440F5BQ35825900-401F4588-E734-49A6-BB39-C93E4FD56A70Q36264053-DD38373E-1583-4037-9B99-E0488836B431Q36406073-4BAE474D-63D7-48A0-96E4-6C98AF32E6CEQ36493920-CA640D8C-B0C1-4CB8-8CE6-6A27C5D9D508Q36513368-E5DD0F14-8029-4A2B-8BF0-1C8E0492F256Q37408761-0E95BB19-FDDB-415A-B0FC-F83828D562E9Q37559503-43A1EC50-08CC-4868-8AA4-18701887E396Q37600475-940B1632-E152-4171-A2B8-F90A5D7EDF29Q37671906-A47EA8C5-01BC-4587-847C-EAE9C3C8C1F6Q38265262-A8D37A26-0939-4E95-82EC-0C73E903C974Q38856995-90DE118F-9444-4B2A-8277-B2E19C174FF9Q40712408-F2833713-1DB8-404B-8201-A33A643341B9Q45076421-D8E54DFB-6811-47D4-882E-08256BF7AA0AQ45296268-215A95B0-9A08-4B09-A2A9-1AF7BE72FB43Q49483102-C711DFE8-EBD0-4C48-A58D-25C3B960A21BQ49599814-C98BA59D-6A8F-422D-8882-72A25100703DQ50944825-7695D49A-BEAB-4EB1-A94D-EEC21F3152ABQ54924379-E59BAB43-9CAC-4769-A77F-41F97C9BE535Q57300648-586BBDD3-BE56-4B54-A0E1-16604232BE0CQ59156231-3A7801B8-EA54-46F7-A3B5-6D1252BB7315
P2860
Determinants of plasma concentrations of perfluoroalkyl substances in pregnant Norwegian women.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Determinants of plasma concent ...... s in pregnant Norwegian women.
@ast
Determinants of plasma concent ...... s in pregnant Norwegian women.
@en
type
label
Determinants of plasma concent ...... s in pregnant Norwegian women.
@ast
Determinants of plasma concent ...... s in pregnant Norwegian women.
@en
prefLabel
Determinants of plasma concent ...... s in pregnant Norwegian women.
@ast
Determinants of plasma concent ...... s in pregnant Norwegian women.
@en
P2093
P2860
P50
P1476
Determinants of plasma concent ...... es in pregnant Norwegian women
@en
P2093
A L Brantsæter
A Sabaredzovic
J A Hoppin
T A Ydersbond
P2860
P356
10.1016/J.ENVINT.2012.12.014
P50
P577
2013-02-15T00:00:00Z